Menu

Image of the Day: Original Fin

Researchers identify the genetics underlying the development of dorsal fins in ancient fish.

Apr 2, 2018
The Scientist Staff, The Scientist Staff

A Japanese rice fish (Oryzias latipes) with normal dorsal and paired pectoral/pelvic fins (top). When the ZRS and sZRS enhancers are knocked out, the fins do not develop normally (bottom).J. LETELIER ET AL.

In a study published last month (March 19) in Nature Genetics, scientists found a single genetic enhancer, named ZRS, critical for normal dorsal fin development in Japanese rice fish (Oryzias latipes). In ancient organisms, dorsal fins are the first limbs seen in the fossil record, indicating they were the first to evolve. When the enhancers were deleted in mice, the rodents also developed abnormal limbs, meaning the pathways that evolved in ancient fins have been conserved across all vertebrates.    

J. Letelier et al., “A conserved Shh cis-regulatory module highlights a common developmental origin of unpaired and paired fins,” Nature Genetics, doi:10.1038/s41588-018-0080-5, 2018.

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.